Sign In
Section Navigation
Common TitleSUPPORT
Official Title A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Phase Phase III
ClinicalTrials.gov NCT00727597
Treatments
Efavirenz
Efavirenz Sustiva

Efavirenz

Tradename:SustivaOther Names:EFVClass:Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
Categories PharmacologyTreatment-NaiveAdverse Effects
Funding
Non-IndustryGeorgetown University
References
  • Kumar P, DeJesus E, Huhn G, et al. Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results. BMC Infect Dis. 2013;13:269.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.